BioSpace News Archive

Business

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

October 24, 2018
·
3 min read
Business

SIRIO Pharma opens multimillion gummy production plant[1] at new high-tech nutraceutical facility in Ma’anshan, China

The new ‘Centre of Excellence’ already boasts one of the world’s most advanced gummy production line designed to meet demand from global markets

October 24, 2018
·
3 min read
Job Trends

Bendcare Endorses Vectra® Testing for Patients with Rheumatoid Arthritis

Vectra Provides Important Information to Help Rheumatologists Identify Patients at Increased Risk of Joint Damage

October 24, 2018
·
7 min read
Deals

Aclaris Announces Pricing of Public Offering of Common Stock of $10.75 Per Share

Aclaris Therapeutics, Inc. today announced the pricing of its underwritten public offering of 8,645,000 shares of its common stock at a price to the public of $10.75 per share.

October 24, 2018
·
4 min read
Deals

Osmotica Pharmaceuticals plc Announces Pricing of Initial Public Offering

Osmotica Pharmaceuticals plc today announced the pricing of its initial public offering of 6,650,000 ordinary shares at a public offering price of $7.00 per share.

October 24, 2018
·
2 min read
Deals

PhaseBio Announces Pricing of Initial Public Offering

PhaseBio Pharmaceuticals, Inc. today announced the pricing of its initial public offering of 9,200,000 shares of common stock at a price to the public of $5.00 per share, for total gross proceeds of approximately $46.0 million.

October 24, 2018
·
2 min read
Accurate evaluation of chondral injuries by near infrared spectroscopy

Osteoarthritis is a disabling disease characterised by joint pain and restricted mobility, affecting especially the elderly.

October 24, 2018
·
3 min read
Drug Development

BioArctic: Eisai to present additional data from BAN2401 Phase 2b study in early Alzheimer’s disease and the presentation will be webcast live from CTAD

BioArctic AB announced today that Eisai will present additional data on the anti-amyloid (Aβ) protofibril antibody BAN2401 clinical Phase 2b study at the 11th Clinical Trials on Alzheimer’s Disease (CTAD) conference, October 24-27, 2018 in Barcelona, Spain.

October 24, 2018
·
5 min read
Combioxin Announces an Oral Presentation on CAL02 clinical results at ESICM 2018

Combioxin SA announced today that first-in-human clinical results with CAL02 in severe pneumonia patients in ICU will be presented during the ESICM’s annual congress, LIVES 2018, taking place October 20-24, 2018 in Paris, France.

October 24, 2018
·
1 min read
Business

Alexion and Dicerna Collaborate to Develop Therapies for Complement-Mediated Diseases

Shares of Alexion Pharmaceuticals are up nearly 4 percent in premarket trading after the company announced it has teamed up with Dicerna Pharmaceuticals on the development of an RNAi therapeutic for the treatment of complement-mediated diseases.

October 24, 2018
·
2 min read
·
Alex Keown